When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
UROV - Urovant up 5% on successful late-stage vibegron studies
Urovant Sciences Ltd.
Thinly traded micro cap Urovant Sciences (UROV+5.1%) bucks the broad market selloff, albeit on light volume. Detailed results from the Phase 3 EMPOWUR study assessing vibegron in overactive bladder patients were presented yesterday at the American Urological Association Annual Meeting in Chicago. The company first announced the successful outcome in March.
More news on: Urovant Sciences Ltd., Healthcare stocks news, Stocks on the move,